Identification of Dipeptidyl Peptidase (DPP) Family Genes in Clinical Breast Cancer Patients via an Integrated Bioinformatics Approach

Breast cancer is a heterogeneous disease involving complex interactions of biological processes; thus, it is important to develop therapeutic biomarkers for treatment. Members of the dipeptidyl peptidase (DPP) family are metalloproteases that specifically cleave dipeptides. This family comprises sev...

Full description

Bibliographic Details
Main Authors: Tak-Kee Choy, Chih-Yang Wang, Nam Nhut Phan, Hoang Dang Khoa Ta, Gangga Anuraga, Yen-Hsi Liu, Yung-Fu Wu, Kuen-Haur Lee, Jian-Ying Chuang, Tzu-Jen Kao
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/11/7/1204
_version_ 1797527300928962560
author Tak-Kee Choy
Chih-Yang Wang
Nam Nhut Phan
Hoang Dang Khoa Ta
Gangga Anuraga
Yen-Hsi Liu
Yung-Fu Wu
Kuen-Haur Lee
Jian-Ying Chuang
Tzu-Jen Kao
author_facet Tak-Kee Choy
Chih-Yang Wang
Nam Nhut Phan
Hoang Dang Khoa Ta
Gangga Anuraga
Yen-Hsi Liu
Yung-Fu Wu
Kuen-Haur Lee
Jian-Ying Chuang
Tzu-Jen Kao
author_sort Tak-Kee Choy
collection DOAJ
description Breast cancer is a heterogeneous disease involving complex interactions of biological processes; thus, it is important to develop therapeutic biomarkers for treatment. Members of the dipeptidyl peptidase (DPP) family are metalloproteases that specifically cleave dipeptides. This family comprises seven members, including DPP3, DPP4, DPP6, DPP7, DPP8, DPP9, and DPP10; however, information on the involvement of DPPs in breast cancer is lacking in the literature. As such, we aimed to study their roles in this cancerous disease using publicly available databases such as cBioportal, Oncomine, and Kaplan–Meier Plotter. These databases comprise comprehensive high-throughput transcriptomic profiles of breast cancer across multiple datasets. Furthermore, together with investigating the messenger RNA expression levels of these genes, we also aimed to correlate these expression levels with breast cancer patient survival. The results showed that DPP3 and DPP9 had significantly high expression profiles in breast cancer tissues relative to normal breast tissues. High expression levels of DPP3 and DPP4 were associated with poor survival of breast cancer patients, whereas high expression levels of DPP6, DPP7, DPP8, and DPP9 were associated with good prognoses. Additionally, positive correlations were also revealed of DPP family genes with the cell cycle, transforming growth factor (TGF)-beta, kappa-type opioid receptor, and immune response signaling, such as interleukin (IL)-4, IL6, IL-17, tumor necrosis factor (TNF), and interferon (IFN)-alpha/beta. Collectively, DPP family members, especially DPP3, may serve as essential prognostic biomarkers in breast cancer.
first_indexed 2024-03-10T09:41:59Z
format Article
id doaj.art-452a2186c703486eb2c8fc000925b762
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-10T09:41:59Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-452a2186c703486eb2c8fc000925b7622023-11-22T03:34:14ZengMDPI AGDiagnostics2075-44182021-07-01117120410.3390/diagnostics11071204Identification of Dipeptidyl Peptidase (DPP) Family Genes in Clinical Breast Cancer Patients via an Integrated Bioinformatics ApproachTak-Kee Choy0Chih-Yang Wang1Nam Nhut Phan2Hoang Dang Khoa Ta3Gangga Anuraga4Yen-Hsi Liu5Yung-Fu Wu6Kuen-Haur Lee7Jian-Ying Chuang8Tzu-Jen Kao9Department of Surgery, Division of Gastroenterologic Surgery, Yuan’s General Hospital, Kaohsiung 80249, TaiwanPhD Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, TaiwanNTT Institute of Hi-Technology, Nguyen Tat Thanh University, Ho Chi Minh City 700000, VietnamPhD Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, TaiwanPhD Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, TaiwanSchool of Chinese Medicine for Post-Baccalaureate, I-Shou University, Kaohsiung 82445, TaiwanNational Defense Medical Center, Department of Medical Research, School of Medicine, Tri-Service General Hospital, Taipei 11490, TaiwanPhD Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, TaiwanGraduate Institute of Neural Regenerative Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, TaiwanGraduate Institute of Neural Regenerative Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, TaiwanBreast cancer is a heterogeneous disease involving complex interactions of biological processes; thus, it is important to develop therapeutic biomarkers for treatment. Members of the dipeptidyl peptidase (DPP) family are metalloproteases that specifically cleave dipeptides. This family comprises seven members, including DPP3, DPP4, DPP6, DPP7, DPP8, DPP9, and DPP10; however, information on the involvement of DPPs in breast cancer is lacking in the literature. As such, we aimed to study their roles in this cancerous disease using publicly available databases such as cBioportal, Oncomine, and Kaplan–Meier Plotter. These databases comprise comprehensive high-throughput transcriptomic profiles of breast cancer across multiple datasets. Furthermore, together with investigating the messenger RNA expression levels of these genes, we also aimed to correlate these expression levels with breast cancer patient survival. The results showed that DPP3 and DPP9 had significantly high expression profiles in breast cancer tissues relative to normal breast tissues. High expression levels of DPP3 and DPP4 were associated with poor survival of breast cancer patients, whereas high expression levels of DPP6, DPP7, DPP8, and DPP9 were associated with good prognoses. Additionally, positive correlations were also revealed of DPP family genes with the cell cycle, transforming growth factor (TGF)-beta, kappa-type opioid receptor, and immune response signaling, such as interleukin (IL)-4, IL6, IL-17, tumor necrosis factor (TNF), and interferon (IFN)-alpha/beta. Collectively, DPP family members, especially DPP3, may serve as essential prognostic biomarkers in breast cancer.https://www.mdpi.com/2075-4418/11/7/1204DPP family genesbreast cancerbioinformatics
spellingShingle Tak-Kee Choy
Chih-Yang Wang
Nam Nhut Phan
Hoang Dang Khoa Ta
Gangga Anuraga
Yen-Hsi Liu
Yung-Fu Wu
Kuen-Haur Lee
Jian-Ying Chuang
Tzu-Jen Kao
Identification of Dipeptidyl Peptidase (DPP) Family Genes in Clinical Breast Cancer Patients via an Integrated Bioinformatics Approach
Diagnostics
DPP family genes
breast cancer
bioinformatics
title Identification of Dipeptidyl Peptidase (DPP) Family Genes in Clinical Breast Cancer Patients via an Integrated Bioinformatics Approach
title_full Identification of Dipeptidyl Peptidase (DPP) Family Genes in Clinical Breast Cancer Patients via an Integrated Bioinformatics Approach
title_fullStr Identification of Dipeptidyl Peptidase (DPP) Family Genes in Clinical Breast Cancer Patients via an Integrated Bioinformatics Approach
title_full_unstemmed Identification of Dipeptidyl Peptidase (DPP) Family Genes in Clinical Breast Cancer Patients via an Integrated Bioinformatics Approach
title_short Identification of Dipeptidyl Peptidase (DPP) Family Genes in Clinical Breast Cancer Patients via an Integrated Bioinformatics Approach
title_sort identification of dipeptidyl peptidase dpp family genes in clinical breast cancer patients via an integrated bioinformatics approach
topic DPP family genes
breast cancer
bioinformatics
url https://www.mdpi.com/2075-4418/11/7/1204
work_keys_str_mv AT takkeechoy identificationofdipeptidylpeptidasedppfamilygenesinclinicalbreastcancerpatientsviaanintegratedbioinformaticsapproach
AT chihyangwang identificationofdipeptidylpeptidasedppfamilygenesinclinicalbreastcancerpatientsviaanintegratedbioinformaticsapproach
AT namnhutphan identificationofdipeptidylpeptidasedppfamilygenesinclinicalbreastcancerpatientsviaanintegratedbioinformaticsapproach
AT hoangdangkhoata identificationofdipeptidylpeptidasedppfamilygenesinclinicalbreastcancerpatientsviaanintegratedbioinformaticsapproach
AT ganggaanuraga identificationofdipeptidylpeptidasedppfamilygenesinclinicalbreastcancerpatientsviaanintegratedbioinformaticsapproach
AT yenhsiliu identificationofdipeptidylpeptidasedppfamilygenesinclinicalbreastcancerpatientsviaanintegratedbioinformaticsapproach
AT yungfuwu identificationofdipeptidylpeptidasedppfamilygenesinclinicalbreastcancerpatientsviaanintegratedbioinformaticsapproach
AT kuenhaurlee identificationofdipeptidylpeptidasedppfamilygenesinclinicalbreastcancerpatientsviaanintegratedbioinformaticsapproach
AT jianyingchuang identificationofdipeptidylpeptidasedppfamilygenesinclinicalbreastcancerpatientsviaanintegratedbioinformaticsapproach
AT tzujenkao identificationofdipeptidylpeptidasedppfamilygenesinclinicalbreastcancerpatientsviaanintegratedbioinformaticsapproach